New cholesterol guidelines from the American Heart Association and the American College of Cardiology recommend adding ezetimibe and/or PCSK9 inhibitors to statin therapy for select high-risk patients, and also propose using coronary artery calcium (CAC) scoring as “a tiebreaker” to guide statin decisions for those at intermediate risk of atherosclerotic cardiovascular disease.

Exposure to blue light could decrease an individual’s systolic blood pressure by as much as 8 mm Hg in just half an hour, researchers report in a study co-led by the University of Surrey, Heinrich Heine University Düsseldorf and Philips.

Up to a quarter of type 1 diabetes patients in England should have access to the Freestyle Libre, a flash glucose monitor that allows diabetics to check their blood sugar without the need for finger pricks. But a recent investigation by the BMJ has concluded that, in reality, just 3 to 5 percent of eligible patients have access to the potentially life-changing technology.

It’s not just what people eat—but when—that may influence their risk of developing prediabetes and high blood pressure, according to preliminary research scheduled to be presented Nov. 10 at the American Heart Association’s Scientific Sessions in Chicago.

Climbing rates of violent crime could trigger blood pressure (BP) spikes within nearby communities—particularly among individuals living in what are considered “safe” neighborhoods—according to a study of 50,000 adults living in Chicago.

Roux-en-Y gastric bypass (RYGB) is linked to greater weight loss compared to two other bariatric procedures but also the highest risk of adverse events in the short term, researchers reported in the Annals of Internal Medicine.

Cannabis use is associated with double the risk of diabetic ketoacidosis among patients with type 1 diabetes, according to a research letter published Nov. 5 in JAMA Internal Medicine.

A 13-year study of type 2 diabetes patients has found metformin, one of the world’s highest-grossing anti-diabetic medications, could be protective against age-related macular degeneration, a leading cause of blindness in Americans older than 50.